Emisphere Technologies Inc. (fka EMIS)

[Small Time Tina]

Emisphere Launches Eligen B12™, the First Oral Prescription Tablet Proven to Normalize B12 Levels Without the Need for an Injection
- Oral tablet offers prescription strength B12 option for the estimated 48 million Americans with a B12 deficiency
- Eligen® Technology being studied across multiple disease states, including diabetes
- Eligen B12 marks Emisphere's expansion into commercializing practical innovations

PR Newswire Emisphere Technologies, Inc.
Mar 19, 2015 8:15 AM
ROSELAND, N.J., March 19, 2015 /PRNewswire/ -- Emisphere Technologies, Inc. (EMIS) today announced the U.S. commercial availability of Eligen B12™, the first and only once-daily oral prescription medical food tablet shown to normalize B12 levels without the need for an injection. Eligen B12 is indicated for the dietary management of patients who have a medically-diagnosed vitamin B12 deficiency, associated with a disease or condition that cannot be managed by a modification of the normal diet alone.

Experience the interactive Multimedia News Release here
http://www.multivu.com/players/English/7467651-emisphere-technologies-eligen-b12/